Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Months 3 to 6: Weight loss continues but the pace slows compared to the first three months
Cagrilintide is a long-acting amylin analogue that reduces appetite and slows gastric emptying, whilst retatrutide is a triple GLP-1, GIP, and glucagon receptor agonist designed to reduce appetite and increase energy expenditure
Every patient is different, and the physician and patient need to understand each others expectations, weigh the risks and benefits and arrive at a mutual decision
Bring a comprehensive list of your current symptoms, medications, and any previous lab work
These medications work by slowing gastric emptying, enhancing satiety, and reducing cravings
It is approved and prescribed for chronic weight management in people who are overweight or obese
US$ 20.90
US$ 23.04
US$ 25.88
US$ 22.01
US$ 20.11
US$ 29.08
US$ 29.39
